Ginkgo Bioworks Holdings Cash Flow-to-Debt Ratio
Ginkgo Bioworks Holdings cash flow-to-debt ratio. Ginkgo Bioworks Holdings (DNA) has a Cash Flow-to-Debt Ratio of -0.08x as of June 2026, meaning its operating cash flow of $-44.27 Million could theoretically repay 0% of its total liabilities ($569.76 Million) in one year. See DNA financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Ginkgo Bioworks Holdings (2019–2025)
Cash flow-to-debt ratio of Ginkgo Bioworks Holdings from 2019 to 2025. Historical debt coverage capacity for Ginkgo Bioworks Holdings across 7 annual periods. Also explore net asset growth rate of Ginkgo Bioworks Holdings to track the company's year-over-year net asset growth rate.
Ginkgo Bioworks Holdings Cash Flow-to-Debt Ratio by Year (2019–2025)
Ginkgo Bioworks Holdings cash flow-to-debt ratio by year from 2019 to 2025. Year-by-year debt coverage analysis for Ginkgo Bioworks Holdings. For the full cash flow conversion analysis, see Ginkgo Bioworks Holdings cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.28x | $-171.06 Million | $611.11 Million | ▲ +42.1% |
| 2024 | -0.48x | $-319.58 Million | $661.39 Million | ▲ +7.1% |
| 2023 | -0.52x | $-295.50 Million | $568.19 Million | ▼ -65.6% |
| 2022 | -0.31x | $-252.20 Million | $803.04 Million | ▲ +37.7% |
| 2021 | -0.50x | $-253.82 Million | $503.61 Million | ▲ +23.9% |
| 2020 | -0.66x | $-135.83 Million | $205.10 Million | ▼ -189.8% |
| 2019 | -0.23x | $-44.66 Million | $195.47 Million | — |